Anti-WFDC5/ PRG5/ WAP1 functional antibody

Anti-WFDC5/ PRG5/ WAP1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to WFDC5/WFDC5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1377-Ab-1/ GM-Tg-hg-SE1377-Ab-2Anti-Human WFDC5 monoclonal antibodyHuman
GM-Tg-rg-SE1377-Ab-1/ GM-Tg-rg-SE1377-Ab-2Anti-Rat WFDC5 monoclonal antibodyRat
GM-Tg-mg-SE1377-Ab-1/ GM-Tg-mg-SE1377-Ab-2Anti-Mouse WFDC5 monoclonal antibodyMouse
GM-Tg-cynog-SE1377-Ab-1/ GM-Tg-cynog-SE1377-Ab-2Anti-Cynomolgus/ Rhesus macaque WFDC5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1377-Ab-1/ GM-Tg-felg-SE1377-Ab-2Anti-Feline WFDC5 monoclonal antibodyFeline
GM-Tg-cang-SE1377-Ab-1/ GM-Tg-cang-SE1377-Ab-2Anti-Canine WFDC5 monoclonal antibodyCanine
GM-Tg-bovg-SE1377-Ab-1/ GM-Tg-bovg-SE1377-Ab-2Anti-Bovine WFDC5 monoclonal antibodyBovine
GM-Tg-equg-SE1377-Ab-1/ GM-Tg-equg-SE1377-Ab-2Anti-Equine WFDC5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1377-Ab-1/ GM-Tg-hg-SE1377-Ab-2; GM-Tg-rg-SE1377-Ab-1/ GM-Tg-rg-SE1377-Ab-2;
GM-Tg-mg-SE1377-Ab-1/ GM-Tg-mg-SE1377-Ab-2; GM-Tg-cynog-SE1377-Ab-1/ GM-Tg-cynog-SE1377-Ab-2;
GM-Tg-felg-SE1377-Ab-1/ GM-Tg-felg-SE1377-Ab-2; GM-Tg-cang-SE1377-Ab-1/ GM-Tg-cang-SE1377-Ab-2;
GM-Tg-bovg-SE1377-Ab-1/ GM-Tg-bovg-SE1377-Ab-2; GM-Tg-equg-SE1377-Ab-1/ GM-Tg-equg-SE1377-Ab-2
Products NameAnti-WFDC5 monoclonal antibody
Formatmab
Target NameWFDC5
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-WFDC5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1377-Ag-1Recombinant multi-species WFDC5/ PRG5/ WAP1 protein


    Target information

    Target IDGM-SE1377
    Target NameWFDC5
    Gene ID149708,296352,711627,610999,101089430,517054,100070884
    Gene Symbol and SynonymsdJ211D12.5,PRG5,WAP1,WFDC5
    Uniprot AccessionQ8TCV5,A4K2T2
    Uniprot Entry NameWFDC5_HUMAN,WFDC5_MACMU
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000175121
    Target ClassificationN/A

    The target: WFDC5, gene name: WFDC5, also named as PRG5, WAP1, dJ211D12.5. This gene encodes a member of the WAP-type four-disulfide core (WFDC) domain family. Most WFDC proteins contain only one WFDC domain, and this encoded protein contains two WFDC domains. The WFDC domain, or WAP signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor. Most WFDC gene members are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene belongs to the centromeric cluster. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.